Original Research

Awareness of cervical cancer prevention among rural dwellers in Enugu State, Nigeria: findings from Ituku outreach

AUTHORS

name here
Polycarp Uchenna Agu
1 Senior Lecturer and Consultant Obstetrician–Gynaecologist

name here
Cyril Chukwudi Dim
1

name here
Johnpaul Ejikeme Nnagbo
1 MBBS, Consultant Gynaecologist * ORCID logo

name here
Godwin Ugonna Odoh
1 Consultant Obstetrician–Gynaecologist

name here
Matthew Ikechukwu Eze
1 MBBS, Consultant Gynaecologist

name here
Onyemaechi Silas Okoro
1 Senior Lecturer and Consultant Obstetrician–Gynaecologist

name here
Peter Onubiwe Nkwo
1 MBBS, Professor

CORRESPONDENCE

*Dr Johnpaul Ejikeme Nnagbo

AFFILIATIONS

1 Department of Obstetrics and Gynaecology, University of Nigeria, Ituku/Ozalla, Enugu State 40001, Nigeria

PUBLISHED

1 May 2026 Volume 26 Issue 2

HISTORY

RECEIVED: 29 May 2025

REVISED: 13 February 2026

ACCEPTED: 16 February 2026

CITATION

Agu PU, Dim CC, Nnagbo JE, Odoh GU, Eze MI, Okoro OS, Nkwo PO.  Awareness of cervical cancer prevention among rural dwellers in Enugu State, Nigeria: findings from Ituku outreach. Rural and Remote Health 2026; 26: 10083. https://doi.org/10.22605/RRH10083

AUTHOR CONTRIBUTIONSgo to url

This work is licensed under a Creative Commons Attribution 4.0 International Licence


Abstract

Introduction: WHO’s global target of eliminating cervical cancer is just 5 years away, and women living in low-resource settings like Nigeria may be left behind, because a significant proportion may not be aware of cervical cancer and its preventive measures. Thus, there is an urgent need to review and possibly scale up awareness of cervical cancer prevention among women residing in rural communities in Nigeria through free medical outreach programs. The aim of this study was to assess the level of awareness and perceptions of cervical cancer prevention among participants of a community health outreach program in Ituku, Enugu State, Nigeria.
Methods
: This mixed-methods study was a quantitative survey of 352 participants and qualitative interviews of 10 purposively selected women attendees at the 2024 free medical outreach at the community of Ituku, Awgu local government area, Enugu State. A pre-tested and validated questionnaire was used to collect data from participants. Quantitative data analysis was done using the Statistical Package for the Social Sciences, while thematic analysis was done for qualitative components.
Results
: Out of 525 eligible women who attended the health outreach, 352 (67.0%) were recruited into the study. Awareness of cervical cancer was reported by 27.8% (n=98) of respondents, while 27.3% (n=96) were aware of cervical cancer screening methods. Only 9.1% (n=32) had heard of HPV vaccination as a preventive measure, and 4.5% (n=16) were aware that HPV infection is a causative factor for cervical cancer. Only 4.5% (n=16) of respondents had ever undergone cervical cancer screening. Awareness of screening methods was associated with age of 40 years or less and being Roman Catholic, while willingness to vaccinate children was associated with having formal education.
Conclusion
: In a rural community in Enugu State, Nigeria, only 3 out of every 10 women were aware of cervical cancer and its preventive measures. Although 1 in every 10 knew that HPV vaccination prevents against cervical cancer, over 9 of 10 of them were willing to vaccinate their children. To join the global community in eliminating cervical cancer by 2030, there is an urgent need to intensify awareness campaigns through outreach programs targeting rural dwellers in low- and middle-income countries about cervical cancer, its etiology and prevention. 

Keywords

cancer aetiology, cancer awareness, cervical cancer, HPV vaccine, vaccination willingness.

Introduction

Cervical cancer remains a significant public health issue in Nigeria, particularly in rural areas, where access to information and medical services is limited. It is one of the leading causes of cancer-related deaths in women globally, especially in low- and middle-income countries. Each year, nearly 350,000 women die from cervical cancer, which is one death every two minutes1. In Nigeria, this imposes a considerable financial burden, as well as psychological and emotional stress on affected families, communities and the country at large2.

Cervical cancer is often described as a preventable cancer3. This is because its primary cause, persistent infection with high-risk strains of HPV, is preventable through vaccination2. Furthermore, the disease typically progresses slowly, offering a window of opportunity for timely detection and treatment of premalignant lesions3,4.

However, evidence suggests that many rural dwellers are not aware of preventive measures such as HPV vaccination and screening for precancerous changes5,6. This lack of awareness in rural Nigeria5 is considered a major barrier to the success of the global cervical cancer elimination initiative, which aims to achieve its targets by 20307.

If a critical population, such as rural dwellers, is unaware that cervical cancer is preventable through HPV vaccination, it is unlikely that Nigeria will achieve the goal of vaccinating 90% of girls aged 9–14 years7. Similarly, it is anticipated that 70% of women would be screened by age 35 years using high-performance tests like HPV testing, but lack of knowledge about screening may make it an unrealistic hope6. Additionally, without awareness of the early signs and symptoms of cervical cancer such as postcoital bleeding, copious foul-smelling vaginal discharge and postmenopausal bleeding, it would be nearly impossible for 90% of affected women to access timely and appropriate treatment7.

The knowledge gap about cervical cancer prevention among rural residents may stem from several factors, including limited access to print and electronic media (such as television and radio), lack of mobile phones or internet connectivity, and low literacy levels8. These barriers highlight the need for health interventions such as targeted medical outreach programs designed to bridge the information gap. Such programs can increase awareness and uptake of cervical cancer prevention strategies, thereby reducing mortality and supporting Nigeria’s contribution to the global goal of eliminating cervical cancer.

To eliminate cervical cancer as a public health threat, WHO has set a global strategy that includes achieving the 90–70–90 targets by 2030: 90% of girls fully vaccinated against HPV by age 15 years, 70% of women screened by age 35 years and again by 45 years, and 90% of women identified with cervical disease receiving appropriate treatment7. Achieving these targets requires increased awareness of cervical cancer – particularly its causes, preventive measures such as screening, and the availability of HPV vaccination. In Nigeria, this need is especially critical in rural populations, which often face disproportionately limited access to health education and preventive services9.

Therefore, evaluating awareness and perceptions of cervical cancer etiology and prevention during the Ituku town health outreach could help identify effective strategies for health education and outreach in similar rural communities. This approach would strengthen Nigeria’s efforts toward aligning with WHO’s cervical cancer elimination goals by 2030.

Methods

Study design

This mixed-methods study comprised cross-sectional quantitative surveys and qualitative interviews of the women at the 2024 Ituku free medical outreach program.

Study area

Ituku is a rural community in the Awgu local government area of Enugu State, Nigeria10. It is one of the host communities of the University of Nigeria Teaching Hospital, Ituku-Ozalla. The town is located approximately 21 km from Enugu City, along the Enugu–Port Harcourt Expressway. Geographically, Ituku lies at latitude 6°17′25″ N and longitude 7°27′15″ E, with a land area of about 2000 hectares10.

The population of Ituku is estimated at about 5000 residents. The majority were born in Ituku, with a smaller proportion comprising immigrant settlers, particularly staff of the University of Nigeria Teaching Hospital. The community is predominantly agrarian, with most residents engaged in farming, while a minority work as civil servants. Women constitute an estimated 60% of the population.

Study population

The study population comprised adult inhabitants of Ituku town including women and men aged 18 years or more who attended the Ituku free medical outreach program. The outreach was a day program organized by Ituku medical practitioners and the Society of Obstetricians and Gynaecologists of Nigeria, Enugu branch. The free medical outreach was approved by the Enugu State Ministry of Health and attended by approximately 700 men, women and children. They were seen by a consultant gynecologist, gynaecology resident doctors, consultant ophthalmologists and GPs.

Sampling

For the cross-sectional arm of the study, convenience sampling of eligible health outreach attendees was utilized. A total sample size of 352 respondents was used for the study. The minimum required sample size was calculated using the Kish formula for prevalence studies: n = 2 × P × (1 – P)/211.

Using a prevalence (P) of cervical cancer awareness in a rural community in the state of Lagos of 15%12, 5% margin of error (d), Z being 1.96 at 95% confidence level, a minimum sample size of 234 after adding 20% non-response rate was obtained. A sample population of 352 was used to increase the study power.

Inclusion criteria

The study eligibility criteria included sexually active women aged 25–65 years, with no history of cervical cancer diagnosis or total hysterectomy. Ten women who were aware of cervical cancer screening methods were purposively selected and interviewed.

Exclusion criteria

Men and children were excluded from the study, as well as women who had resided in Ituku for less than 6 months prior to the health outreach.

Data collection

Prior to data collection, written permission was obtained from Enugu State Ministry of Health, and all eligible participants signed a consent form.

A face-validated and structured interviewer-administered questionnaire assessing knowledge about cervical cancer prevention was used for data collection. An in-depth interview to gain insights into perceived barriers to cervical cancer screening was carried out on selected participants who were aware of cervical cancer. After the questionnaires were administered to the participants by the corresponding author and the obstetrics and gynecology resident doctors (research assistants), we reviewed and identified the 98 who were aware of cervical cancer. With their numbers in the attendance register, a random selection (balloting) was done to select 10 out of the 98 to have the in-depth interview. The selected women answered an extra question: what are the perceived barriers to screening for cervical cancer? This was administered by us on one-by-one basis.

Participants who had ever heard of cervical cancer were considered to be aware of the disease, while those who had heard of any screening method were considered to be aware of cervical cancer screening.

Data analysis

Quantitative analysis was done using the Statistical Package for the Social Sciences v20.0 for Windows (IBM Corp; https://www.ibm.com/products/spss-statistics). Analysis was essentially descriptive, with basic characteristics being illustrated as frequencies and percentages, and presented in tables and figures. Thematic analysis was conducted to identify patterns and key themes from participants’ responses regarding perceived barriers to cervical cancer screening. The analysis followed the six-step framework outlined by Braun and Clarke13.

Ethics approval

Ethics approval was obtained from the Health Research Ethics Committee (HREC) of the University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State; NHREC/05/01/2008B-FWA00002458-1RB00002323.

Results

Of the 525 eligible women who attended the health outreach, 352 (67.0%) were enrolled in the cross-sectional component of the study, with a response rate of 97%. Additionally, 10 women participated in the in-depth interview component. The mean age of respondents was 51±12.6 years while those aged 40 years or more constituted 70% of the population. All respondents were Christians, with a majority (72.7%) being Roman Catholics. In terms of occupation of the participants, many (59.1%) were farmers, with pockets of other occupations. Regarding educational status, 109 (30.9%) respondents had primary education while 38 (10.9%) had tertiary education. Details of the basic sociodemographic characteristics, obstetric and gynecological features of the respondents are as shown in Table 1.

Table 2 shows that only 98 (27.8%) of the respondents were aware of cervical cancer while 16 (4.5%) knew there was an etiological link between persistent HPV infection and cervical cancer. A total of 96 (27.2%) were aware of screening methods. Also, 32 (9.1%) knew that HPV vaccine prevented against cervical cancer. Only 15 (4.0%) of the respondents had ever had cervical cancer screening.

When we explored the association between basic characteristics such as age and educational status, and some variables such as awareness of cervical cancer, awareness of screening methods, awareness of HPV vaccine and respondents’ willingness to vaccinate their daughters, the result showed age was significantly associated with awareness of cervical cancer screening (p<0.0001), HPV vaccination (p<0.0001) and respondents’ willingness to vaccinate their daughters against HPV infection (p<0.0001). Having formal education was also significantly associated with respondents’ willingness to vaccinate their daughters (p<0.0001). Further details of the relationship between these factors can be seen in Table 3.

Among the 96 respondents who were aware of cervical cancer screening, 77 (80.2%) were aware of the Pap smear. Awareness of other screening methods was as follows: 10 respondents (10.4%) were aware of visual inspection with acetic acid, 14 (14.6%) of visual inspection with Lugol’s iodine, 2 (2.1%) of HPV testing, and only 1 respondent (1.0%) was aware of colposcopy.

Additionally, when the willingness of the respondents to vaccinate their daughters against HPV infection was assessed, the study showed that almost all 319 (90.6%) of the respondents were willing. When the 33 (9.4%) who were not willing were asked the reason, 63.6% said it may cause sterility (infertility) in their daughters, 18.1% said they were afraid of the side effects, 12.1% said they did not know much about the vaccine while the remaining 6.2% did have any reason.

During the in-depth interviews, which were conducted by the corresponding author, participants were asked, ‘What are the perceived barriers to screening for cervical cancer?’ The following key barriers emerged from their responses: lack of awareness that screening methods exist, limited access to screening services, the perception that screening may be unaffordable, concerns about pain or discomfort associated with the procedure, and fear of receiving a cancer diagnosis. These themes are summarized in Table 4, with illustrative quotes from participants.

Table 1: Sociodemographic characteristics of study participants (N=352)

Characteristic Variables n %
Age (years) (mean 51±12.6 years) <20 0 0.0
20–40

96

27.3
>40

256

72.7
Christianity Yes 352 100.0
No

0

0.0
Church denomination Roman Catholic 256 72.7
Anglican

32

9.1
Pentecostal

64

18.2
Occupation Farming 208 59.1
Teaching (primary and secondary)

112

31.8
Civil servants

16

4.5
Petty traders

16

4.5
Level of education No formal education 99 28.1
Primary

109

30.9
Secondary

106

30.1
Tertiary

38

10.9
Parity (number of births) 0 38 10.8
1

10

2.9
2–4

80

22.7
>4

224

63.6
Menstrual status Menstruating 202 57.4
Postmenopausal

150

42.6
BMI (kg/m2) <18.5 4 1.2
18.5–24.9

60

17.0
25–29.9

265

75.3
≥30

23

6.5

Table 2: Awareness of cervical cancer and preventive measures (N=352)

Characteristic Variables n %
Awareness of cervical cancer Yes 98 27.8
No

254

72.2
Aware that persistent HPV infection causes cervical cancer Yes 16 4.5
No

336

95.5
Awareness of screening methods Yes 96 27.2
No

256

72.2
Aware that HPV vaccine prevents cervical cancer Yes 32 9.1
No

320

90.9
Ever screened for cervical cancer Yes 15 4.0
No

337

96.0

Table 3: Associations of respondent’s characteristics with cervical cancer prevention and awareness

Characteristic Variables Respondent awareness/willingness p-value Odds ratio 95%CI

Yes

No

n (%)

n (%)

Cervical cancer awareness
Age (years) >40 62 (63.3) 194 (76.4) 0.08 1.60 0.87–2.94
≤40

36 (36.7)

60 (23.6)      
Educational status Any formal education 68 (69.4) 185 (72.8) 0.30 0.85 0.51–1.41
No formal education

30 (30.6)

69 (27.2)      
Roman Catholic? Yes 74 (75.5) 182 (71.7) 0.54 1.23 0.65–2.28
No

24 (24.5)

72 (28.3)      
Awareness of any cervical cancer screening method
Age (years) >40 27 (28.1) 229 (89.5) <0.0001 0.05 0.03–0.08
≤40

69 (71.9)

27 (10.5)      
Educational status Any formal education 65 (67.7) 188 (73.4) 0.18 0.76 0.46–1.26
No formal education

31 (32.3)

68 (26.6)      
Roman Catholic? Yes 59 (60.2) 197 (77.0) 0.03 0.52 0.29–0.95
No

37 (39.8)

59 (23.0)      
Awareness of HPV vaccine for cervical cancer prevention
Age (years) >40 16 (50.0) 256 (80.0) <0.0001 0.25 0.12–0.53
≤40

16 (50.0)

64 (20.0)      
Educational status Any formal education 26 (81.3) 227 (70.9) 0.15 1.78 0.71–4.45
No formal education

6 (18.7)

93 (29.1)      
Roman Catholic? Yes 19 (59.4) 237 (74.1) 0.03 0.51 0.28–0.93
No

13 (40.6)

83 (25.9)      
Willingness to vaccinate children
Age (years) >40 238 (74.6) 18 (54.5) <0.0001 0.25 0.12–0.53
≤40

81 (25.4)

15 (45.5)      
Educational status Any formal education 245 (76.8) 8 (24.4) <0.0001 10.3 5.34–19.7
No formal education

74 (23.2)

25 (75.6)      
Roman Catholic? Yes 249 (78.1) 7 (21.2) <0.0001 13.3 6.76–26.0
No

70 (21.9)

26 (78.8)      

CI, confidence interval

Table 4: Perceived barriers to cervical cancer screening among participants

Emerging theme Illustrative participant quote
Lack of awareness ‘Before today, I didn’t even know there’s a test to check for cervical cancer, not to mention that it can be cured if caught early.’
Limited access to screening ‘All these things are sounding strange to most of us, such service is not in Ituku health center.’
Perceived unaffordability ‘I think one of the problem[s] is that we think it may be high cost.’
Fear of pain or discomfort ‘ ... hmmm me, I am afraid of it oh, is that thing not even painful ... ’
Fear of diagnosis ‘ ... what do they want to see, hmm, I don’t want them to just find out I have cancer, so that I will start worrying about it every day ... ’

Discussion

This study, conducted among women in a rural community in Enugu State, Nigeria, found low levels of awareness about cervical cancer and its screening methods, and identified key barriers to screening uptake within the community. The present study shows that only 27.8% of participants were aware of cervical cancer. This level of awareness is low, particularly when compared to other low- and middle-income countries such as rural South India, where 67% of women were reportedly aware of the disease14. The difference in the rate of awareness between rural South India and Ituku may stem from the differences in the demographic and socioeconomic status of the two populations. In Ituku, despite the predominance of rural farmers who were older, had high parity, low levels of education, predominantly Christian and had limited access to reproductive health information15, these characteristics were not associated with cervical cancer awareness.

The findings align with studies in rural Zimbabwe and parts of Southwest Nigeria like Lagos, which have reported cervical cancer awareness levels of 25% and 27.7%, respectively12,15. However, awareness in Ituku was still considerably higher than the 6.2% reported in rural Benin Republic15 and 12.8% in urban slums of Lagos16. These disparities may be attributed to differences in literacy rates, media exposure and community outreach activities in the various settings. For example, communities with more frequent use of electronic media and mobile health campaigns often report higher levels of awareness17,18. Although being Roman Catholic was not significantly associated with awareness of cervical cancer in this study, religion has been reported as an impediment, especially to screening19. It has also been speculated that religious leaders have strong influence over their followers, which can significantly impact attitudes toward health messages, including those related to the etiology and prevention of cervical cancer. Furthermore, faith communities frequently organize medical outreaches, which can serve as platforms for cervical cancer awareness creation20. Contrary to this, all participants in this study were Christians, yet the level of awareness was very low. Perhaps this low awareness may stem from either a lack of such outreaches or misinformation by religious leaders.

One of the most alarming findings from the study is that only 4% of women reported having ever been screened for cervical cancer. This falls drastically short of WHO’s 70% target and even the Nigerian National Strategic Plan’s more modest goal of screening 50% of eligible women at least once in their lifetime by 20277,21. The low screening uptake seen here mirrors the national trend. Previous studies show generally poor screening rates across Nigeria, with uptake often below 10%, particularly in rural and underserved regions18.

The 4% reported in Ituku is especially low and represents a critical gap in the cervical cancer prevention and control program. If such trends persist, Nigeria risks missing not only global goals but also its own national targets7,21. The data underscore the urgent need for innovative, cost-effective and community-integrated strategies to improve screening uptake in rural and hard-to-reach areas22.

This is particularly pressing considering that screening remains one of the most effective ways to detect cervical lesions early, allowing for timely treatment and greatly reducing mortality. Without improved screening efforts, rural communities will continue to face disproportionately high rates of late-stage diagnosis and cervical cancer-related deaths.

The disproportionate awareness of screening methods, with Pap smear being the most commonly known, may be due to its longer history of use, occasional mentions in antenatal and reproductive health clinics and the fact that age less than 40 years was significantly associated with level of awareness of screening methods in this study. However, the almost negligible awareness of HPV testing and colposcopy is troubling, considering these are central to modern cervical cancer screening algorithms23. The low awareness of visual inspection with acetic acid and visual inspection with Lugol’s iodine, which are cost-effective and recommended by WHO for low-resource settings, suggests missed opportunities in deploying scalable screening solutions in communities like Ituku. These methods are recommended by WHO for low-resource settings due to their simplicity, affordability and effectiveness in detecting precancerous lesions24. Perhaps, even more worrying is the very low awareness of HPV testing, which is now regarded as the most sensitive screening method globally23. HPV testing allows for self-sampling, which can address barriers such as embarrassment and discomfort often associated with clinician-collected samples25. Low awareness of this among rural Nigerian women suggests a missed opportunity to modernize and scale up cervical cancer screening in a way that fits the realities of rural healthcare delivery.

Participants who identified as Roman Catholic had significantly lower odds (75% reduction) of being aware of cervical cancer screening methods compared with non-Catholics. Given that Roman Catholics constituted over 70% of the study population, this finding warrants further investigation. It is unclear whether this association reflects differences in exposure to health information, church-based outreach activities, or other sociocultural factors.

This knowledge gap contrasts starkly with practices in high-income countries, where women are more familiar with and routinely undergo HPV testing26. For Nigeria to achieve meaningful progress, there is a need to popularize HPV testing and make it accessible through primary healthcare centers, especially in rural communities.

The study also identified multiple barriers to cervical cancer screening, which include lack of awareness, limited access to screening services, perceived high cost of screening, fear of pain or discomfort and fear of receiving a cancer diagnosis. These barriers are consistent with a study conducted in Nigeria27. In rural settings, logistical challenges such as transportation, service availability and out-of-pocket costs can deter women from seeking preventive care. Cultural and emotional factors, particularly fear of cancer diagnosis, may also play a role, as many perceive a cancer diagnosis as a death sentence due to poor access to treatment facilities27.

Interestingly, when participants were asked about HPV vaccination for their children, 90.6% expressed willingness to vaccinate. Although such high willingness has been expressed by women in Nigeria28,29, our study showed that it was associated with attaining formal education and age more than 40 years. It also shows a remarkably high level of acceptability and offers a promising opportunity to expand vaccine coverage among adolescents, which is a key pillar in the global cervical cancer elimination strategy.

Among the small proportion who were unwilling to vaccinate their children, 63.6% cited fear of infertility as the main reason. This concern is deeply rooted in a lack of formal education, as well as misinformation and cultural beliefs that tie a woman’s value to her ability to bear children. Fertility-related myths have been documented as barriers to vaccine uptake in many parts of Africa30. These findings indicate the importance of culturally sensitive education campaigns, involving trusted community and religious leaders to dispel myths and reinforce accurate health information.

Overall, the low awareness rate found in this study reflects limited knowledge about the disease’s causes and prevention methods. It underscores the urgent need for intensified, community-focused awareness campaigns that are tailored to the sociocultural and educational context of rural Nigerian women. Such community interventions should be an effective and innovative strategy, as demonstrated by some studies in Africa31,32.

We hope that future researchers can leverage the findings of this study and focus on innovative and culturally sensitive approaches, peer-group education, home visitation or outreach programs tailored for hard-to-reach communities. Emphatically, we recommend more research to understand the reason why being Roman Catholic is associated with low awareness of cervical cancer prevention in Christian-dominated rural communities in Nigeria.

Despite the positive findings of this study it must be carefully interpreted, considering the inherent limitations in questionnaire-based studies. For instance, participants may have had some recall bias, social desirability bias and misinterpretation of questions. Despite this, the qualitative component of the study enabled us to explore the participants’ perceived barriers to screening, hence giving some credence to internal validity of the study.

Conclusion

The findings from this study in the rural community of Ituku paint a stark but clear picture of the current realities surrounding cervical cancer prevention in rural Nigeria. While awareness and uptake of screening remain critically low, there is a promising level of willingness to adopt preventive practices such as HPV vaccination. The study emphasizes the need for multifaceted, community-based strategies that address not just service delivery gaps but also deep-rooted sociocultural barriers.

Achieving WHO’s target of cervical cancer elimination in Nigeria will require bold, sustained and inclusive public health interventions. Rural communities like Ituku must not be left behind. Instead, they should be placed at the heart of these efforts, ensuring that no woman, regardless of where she lives, is denied the right to cervical cancer prevention and care.

Funding

No funding was received for this research.

Conflicts of interest

The authors declare no conflicts of interest.

AI disclosure statement

The authors used ChatGPT-5 to revise article content. The authors have verified the accuracy of, and take responsibility for, the content.

References

1 UNICEF. 5 fast facts about HPV and cervical cancer. UNICEF. https://www.unicef.org/stories/fast-facts-hpv-cervical-cancerweb link (Accessed 2 October 2024).
2 Nwankwo T, Ogunyemi AO, Maduafokwa BA, Isikekpei BC, Alabi AO, Adegboyega BC, et al. Psychosocial support and cost burden of cancer among patients attending tertiary oncology clinics in Lagos State, Nigeria. Asian Pacific Journal of Cancer Prevention 2023; 24(7): 23132319. DOIhttps://doi.org/10.31557/APJCP.2023.24.7.2313 PMid:37505761https://www.ncbi.nlm.nih.gov/pubmed/37505761
3 National Cancer Institute (NCI). Cervical cancer causes, risk factors, and prevention. Bethesda, US: NCI, 2024. https://www.cancer.gov/types/cervical/causes-risk-preventionweb link (Accessed 1 December 2024).
4 Dim CC. Towards improving cervical cancer screening in Nigeria: a review of the basics of cervical neoplasm and cytology. Nigerian Journal of Clinical Practice 2012; 15(3): 247252. DOIhttps://doi.org/10.4103/1119-3077.100615 PMid:22960955https://www.ncbi.nlm.nih.gov/pubmed/22960955
5 Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsagué X, et al. Overall efficacy of HPV16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: a 4-year end-of-study analysis of the randomized, double-blind PATRICIA trial. Lancet Oncology 2012; 13(1): 8999. DOIhttps://doi.org/10.1016/S1470-2045(11)70286-8 PMid:22075171https://www.ncbi.nlm.nih.gov/pubmed/22075171
6 Omowhora OB, Ameh S, Banjo AA. Cervical cancer screening awareness and uptake among under-screened women in a rural Nigerian community. Nigerian Health Journal 2022; 22(4): 428432.
7 World Health Organization (WHO). Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva, Switzerland: WHO, 2020. https://www.who.int/publications/i/item/9789240014107web link (Accessed 1 December 2025).
8 Mantula F, Toefy Y, Sewram V. Barriers to cervical cancer screening in Africa: a systematic review. BMC Public Health 2024; 24: 17842. DOIhttps://doi.org/10.1186/s12889-024-17842-1 PMid:38378542https://www.ncbi.nlm.nih.gov/pubmed/38378542
9 ICO/IARC Information Centre on HPV and Cancer. Home page. Barcelona, Spain: ICO/IARC Information Centre on HPV and Cancer. https://hpvcentre.netweb link (Accessed 25 March 2025).
10 Mapcarta. Ituku, Awgu, Enugu State, Nigeria. Bengaluru, India: Mapcarta. https://mapcarta.com/17019636web link (Accessed 9 July 2025).
11 Kish L. Survey sampling. New York, USA: John Wiley & Sons, 1965.
12 Oluwole E O, Mohammed A S, Akinyika M R, Salako O. Cervical cancer awareness and screening uptake among rural women in Lagos. Journal of Community Medicine and Primary Health Care 2017; 29(1): 8188.
13 Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology 2006; 3(2): 77101. DOIhttps://doi.org/10.1191/1478088706qp063oa
14 Ghosh S, Mallya S D, Pattanshetty S M, Pandey D, Kamath V G, Kabekkodu S P, et al. Awareness, attitude, and practice towards cancer cervix prevention among rural women in southern India: a community-based study. Clinical Epidemiology & Global Health 2024; 16: 101360. DOIhttps://doi.org/10.1016/j.cegh.2024.101546
15 Barron A, Onikan A, Nzoputam A I, Ekholuenetale M. Prevalence and determinants of cervical cancer awareness among women of reproductive age: evidence from Benin and Zimbabwe population-based data. Applied Cancer Research 2020; 40: 11. DOIhttps://doi.org/10.1186/s41241-020-00092-z
16 Olubodun T, Odukoya O O, Balogun M R. Knowledge, attitude and practice of cervical cancer prevention among women residing in an urban slum in Lagos, Southwest Nigeria. Pan African Medical Journal 2019; 32: 130134. DOIhttps://doi.org/10.11604/pamj.2019.32.130.14432 PMid:31223418https://www.ncbi.nlm.nih.gov/pubmed/31223418
17 Wamai R G, Ayissi C A, Oduwo G O, Perlman S, Welty E, Manga S, et al. Assessing the effectiveness of a community-based sensitization strategy in creating awareness about HPV, cervical cancer and HPV vaccine among parents in North West Cameroon. Journal of Community Health 2012; 37(5): 917926. DOIhttps://doi.org/10.1007/s10900-012-9540-5 PMid:22302651https://www.ncbi.nlm.nih.gov/pubmed/22302651
18 Yimer N B, Mohammed M A, Solomon K, Tadese M, Grutzmacher S, Meikena H K, et al. Cervical cancer screening uptake in sub-Saharan Africa: a systematic review and meta-analysis. Public Health 2021; 195: 105111. DOIhttps://doi.org/10.1016/j.puhe.2021.04.014 PMid:34082174https://www.ncbi.nlm.nih.gov/pubmed/34082174
19 Gutusa F, Roets L. Early cervical cancer screening: the influence of culture and religion. African Journal of Primary Health Care & Family Medicine 2023; 15(1): e1e6. DOIhttps://doi.org/10.4102/phcfm.v15i1.3776 PMid:36744462https://www.ncbi.nlm.nih.gov/pubmed/36744462
20 Onwuka C, Umezuruike C, Hendricks C E, Eguzo K. Religious gathering as a tool for collaborative cervical cancer prevention: report from Nigeria. Journal of Global Oncology 2018; 4: 137s. DOIhttps://doi.org/10.1200/jgo.18.759
21 National Taskforce on Cervical Cancer Elimination. Home page. Abuja, Nigeria: National Taskforce on Cervical Cancer Elimination. https://www.linkedin.com/company/national-taskforce-on-cervical-cancer-elimination-ntf-cceweb link (Accessed 18 May 2025).
22 Abah AU, Omokhapue A, Adefisoye A, Usifoh N, Iyanuoluwa OA. Environmental and psychosocial predictors of cervical cancer screening among women in Gwagwalada Area Council, Abuja, North Central, Nigeria. African Journal of Reproductive Health 2023; 27(7): 3242. DOIhttps://doi.org/10.29063/ajrh2023/v27i7.4 PMid:37742332https://www.ncbi.nlm.nih.gov/pubmed/37742332
23 Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. New England Journal of Medicine 2007; 357(16): 15791588. DOIhttps://doi.org/10.1056/NEJMoa071430 PMid:17942871https://www.ncbi.nlm.nih.gov/pubmed/17942871
24 World Health Organization (WHO). Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy: a demonstration project in six African countries. Geneva, Switzerland: WHO, 2012. https://www.who.int/publications/i/item/9789241503860web link (Accessed 3 February 2026).
25 World Health Organization (WHO). WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention 2nd edn. Geneva, Switzerland: WHO, 2021. https://www.who.int/publications/i/item/9789240030824web link (Accessed 20 May 2025).
26 Fontham TH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA: A Cancer Journal for Clinicians 2020; 70(5): 321346. DOIhttps://doi.org/10.3322/caac.21628 PMid:32729638https://www.ncbi.nlm.nih.gov/pubmed/32729638
27 Okolie EA, Barker D, Nnyanzi LA, Anjorin S, Aluga D, Nwadike BI. Factors influencing cervical cancer screening practice among female health workers in Nigeria: a systematic review. Cancer Reports 2022; 5(5): e1514. DOIhttps://doi.org/10.1002/cnr2.1514 PMid:34313402https://www.ncbi.nlm.nih.gov/pubmed/34313402
28 Ezenwa BN, Balogun MR, Okafor IP. Mothers’ human papilloma virus knowledge and willingness to vaccinate their adolescent daughters in Lagos, Nigeria. International Journal of Women's Health 2013; 5: 371377. DOIhttps://doi.org/10.2147/IJWH.S44483 PMid:23874123https://www.ncbi.nlm.nih.gov/pubmed/23874123
29 Okagbue HI, Erekosima G, Sampson S, Atuhaire B, Samuel O, Chimezie B, et al. Predictors of willingness of HPV vaccine uptake across eight states in Nigeria. BMC Public Health 2025; 25: 745. DOIhttps://doi.org/10.1186/s12889-025-22000-2 PMid:39994628https://www.ncbi.nlm.nih.gov/pubmed/39994628
30 Heyde S, Osmani V, Schauberger G, Cooney C, Klug SJ. Global parental acceptance, attitudes, and knowledge regarding human papillomavirus vaccinations for their children: a systematic literature review and meta-analysis. BMC Women's Health 2024; 24: 537. DOIhttps://doi.org/10.1186/s12905-024-03377-5 PMid:39334328https://www.ncbi.nlm.nih.gov/pubmed/39334328
31 Adebola AO, Smith-Okonu ST. Cervical cancer screening among urban women in Lagos, Nigeria: focus on barriers and motivators for screening. Nigerian Journal of General Practice 2020; 18(1): 1016. DOIhttps://doi.org/10.4103/NJGP.NJGP_6_19
32 Makadzange EE, Peeters A, Joore MA, Kimman ML. The effectiveness of health education interventions on cervical cancer prevention in Africa: a systematic review. Preventive Medicine 2022; 164: 107219. DOIhttps://doi.org/10.1016/j.ypmed.2022.107219 PMid:36007752https://www.ncbi.nlm.nih.gov/pubmed/36007752